Comments & Letters

Joint Statement Regarding Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; Proposed Rule (CMS-1695-P)

A Joint Perspective on Tolerable Risk in Blood Safety

Joint Statement to the Food and Drug Administration’s Blood Product Advisory Committee – Strategies to Control the Risk of Bacterial Contamination in Platelets for Transfusion

Joint Response to CMS-1694-P: Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Proposed Policy Changes and Fiscal Year 2019 Rates

Joint Response to Senate HELP Draft PAHPA Discussion

Statement of America’s Blood Centers Hearing on “Preparedness, Response, and Rebuilding: Lessons from the 2017 Disasters” U.S. House of Representatives Homeland Security Committee March 14, 2018

Joint Comments on Request for Removal of Hydroxyethyl Starch from the U.S. Market